Annual Net Income
-$94.66 M
-$13.76 M-17.00%
December 31, 2021
Summary
- As of February 10, 2025, SRRA annual net profit is -$94.66 million, with the most recent change of -$13.76 million (-17.00%) on December 31, 2021.
- During the last 3 years, SRRA annual net income has fallen by -$41.32 million (-77.48%).
Performance
SRRA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Net Income
-$27.93 M
-$2.46 M-9.66%
March 31, 2022
Summary
- As of February 10, 2025, SRRA quarterly net profit is -$27.93 million, with the most recent change of -$2.46 million (-9.66%) on March 31, 2022.
- Over the past year, SRRA quarterly net income has dropped by -$8.01 million (-40.24%).
Performance
SRRA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Net Income
-$102.67 M
-$8.01 M-8.47%
March 31, 2022
Summary
- As of February 10, 2025, SRRA TTM net profit is -$102.67 million, with the most recent change of -$8.01 million (-8.47%) on March 31, 2022.
- Over the past year, SRRA TTM net income has dropped by -$33.77 million (-49.01%).
Performance
SRRA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
SRRA Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.0% | -40.2% | -49.0% |
| 3 y3 years | -77.5% | -114.3% | -16.3% |
| 5 y5 years | -125.3% | -151.8% | -16.3% |
SRRA Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | +9.7% | at low | +8.5% | at low |
| 5 y | 5-year | +17.0% | at low | +92.5% | +69.9% | +49.0% | +7.5% |
| alltime | all time | +1285.5% | at low | +1032.1% | +69.9% | +4061.8% | +7.5% |
Sierra Oncology Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$27.93 M(+9.7%) | -$102.67 M(+8.5%) |
| Dec 2021 | -$94.66 M(+17.0%) | -$25.47 M(-11.1%) | -$94.66 M(+8.5%) |
| Sep 2021 | - | -$28.65 M(+38.9%) | -$87.22 M(+19.4%) |
| Jun 2021 | - | -$20.63 M(+3.6%) | -$73.07 M(+6.0%) |
| Mar 2021 | - | -$19.91 M(+10.5%) | -$68.91 M(-14.8%) |
| Dec 2020 | -$80.90 M(-8.4%) | -$18.02 M(+24.3%) | -$80.90 M(-26.7%) |
| Sep 2020 | - | -$14.51 M(-11.9%) | -$110.34 M(+1.5%) |
| Jun 2020 | - | -$16.46 M(-48.4%) | -$108.74 M(+1.5%) |
| Mar 2020 | - | -$31.91 M(-32.8%) | -$107.16 M(+21.4%) |
| Dec 2019 | -$88.28 M(+65.5%) | -$47.46 M(+267.8%) | -$88.28 M(+60.2%) |
| Sep 2019 | - | -$12.90 M(-13.3%) | -$55.10 M(-4.6%) |
| Jun 2019 | - | -$14.88 M(+14.2%) | -$57.76 M(+5.3%) |
| Mar 2019 | - | -$13.03 M(-8.8%) | -$54.84 M(+2.8%) |
| Dec 2018 | -$53.34 M(+26.9%) | -$14.28 M(-8.2%) | -$53.34 M(+7.4%) |
| Sep 2018 | - | -$15.57 M(+30.2%) | -$49.65 M(+12.6%) |
| Jun 2018 | - | -$11.96 M(+3.8%) | -$44.08 M(+3.8%) |
| Mar 2018 | - | -$11.53 M(+8.7%) | -$42.45 M(+1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | -$42.02 M(-12.2%) | -$10.60 M(+6.0%) | -$42.02 M(+3.3%) |
| Sep 2017 | - | -$9.99 M(-3.2%) | -$40.66 M(-11.4%) |
| Jun 2017 | - | -$10.33 M(-6.9%) | -$45.88 M(-5.3%) |
| Mar 2017 | - | -$11.09 M(+19.9%) | -$48.42 M(+1.2%) |
| Dec 2016 | -$47.87 M(-10.1%) | -$9.25 M(-39.2%) | -$47.87 M(-4.4%) |
| Sep 2016 | - | -$15.21 M(+18.2%) | -$50.08 M(-6.2%) |
| Jun 2016 | - | -$12.87 M(+22.1%) | -$53.37 M(-4.3%) |
| Mar 2016 | - | -$10.54 M(-8.0%) | -$55.75 M(+4.7%) |
| Dec 2015 | -$53.26 M(+123.1%) | -$11.46 M(-38.1%) | -$53.26 M(+17.3%) |
| Sep 2015 | - | -$18.50 M(+21.4%) | -$45.42 M(+47.1%) |
| Jun 2015 | - | -$15.25 M(+89.5%) | -$30.88 M(+4.8%) |
| Mar 2015 | - | -$8.05 M(+122.3%) | -$29.45 M(+23.4%) |
| Dec 2014 | -$23.87 M(+249.4%) | -$3.62 M(-8.6%) | -$23.87 M(+17.9%) |
| Sep 2014 | - | -$3.96 M(-71.3%) | -$20.25 M(+24.3%) |
| Jun 2014 | - | -$13.82 M(+460.4%) | -$16.29 M(+560.4%) |
| Mar 2014 | - | -$2.47 M | -$2.47 M |
| Dec 2013 | -$6.83 M | - | - |
FAQ
- What is Sierra Oncology annual net profit?
- What is the all time high annual net income for Sierra Oncology?
- What is Sierra Oncology annual net income year-on-year change?
- What is Sierra Oncology quarterly net profit?
- What is the all time high quarterly net income for Sierra Oncology?
- What is Sierra Oncology quarterly net income year-on-year change?
- What is Sierra Oncology TTM net profit?
- What is the all time high TTM net income for Sierra Oncology?
- What is Sierra Oncology TTM net income year-on-year change?
What is Sierra Oncology annual net profit?
The current annual net income of SRRA is -$94.66 M
What is the all time high annual net income for Sierra Oncology?
Sierra Oncology all-time high annual net profit is -$6.83 M
What is Sierra Oncology annual net income year-on-year change?
Over the past year, SRRA annual net profit has changed by -$13.76 M (-17.00%)
What is Sierra Oncology quarterly net profit?
The current quarterly net income of SRRA is -$27.93 M
What is the all time high quarterly net income for Sierra Oncology?
Sierra Oncology all-time high quarterly net profit is -$2.47 M
What is Sierra Oncology quarterly net income year-on-year change?
Over the past year, SRRA quarterly net profit has changed by -$8.01 M (-40.24%)
What is Sierra Oncology TTM net profit?
The current TTM net income of SRRA is -$102.67 M
What is the all time high TTM net income for Sierra Oncology?
Sierra Oncology all-time high TTM net profit is -$2.47 M
What is Sierra Oncology TTM net income year-on-year change?
Over the past year, SRRA TTM net profit has changed by -$33.77 M (-49.01%)